Joseph de Gruy, MD
Otolaryngology · Flowood, MSNPI 1750874145
Payments from drug & device makers
What this record shows
Inspire Medical Systems, Inc. accounts for 73.8% of it on its own, with 7 other manufacturers making up the rest. Reporting peaked in 2024 at $1,271 and has fallen 72.1% since, to $355 in 2025.
Across 19 payments — averaging $107.15 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Inspire Medical Systems, Inc.$2K
- Integra Lifesciences Corporation$161
- Sanofi$123
- Regeneron Healthcare Solutions, Inc.$77
- Stryker$70
- Zimmer Biomet$42
- plus $60 from 2 others
What the payments were for
- Travel & lodging$95547%
- Food & beverage$1,08153%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Inspire Medical Systems, Inc. | 9 | $1,503 |
| Integra Lifesciences Corporation | 1 | $161 |
| Sanofi | 1 | $123 |
| Regeneron Healthcare Solutions, Inc. | 4 | $77 |
| Stryker | 1 | $70 |
| Zimmer Biomet | 1 | $42 |
| Intuitive Surgical | 1 | $36 |
| GSK | 1 | $23 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Inspire$1,366
- Acclarent Aera$161
- Inspira Air$161
- RELIEVA SPINPLUS NAV$161
- TruDi Probe$161
- DUPIXENT$123
How this compares
$2,036 in reported general payments places this provider in the 65th percentile of 97 otolaryngology providers in Mississippi.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Ipratropium Bromide | 49 | $1,374 |
| Fluticasone Propionate | 27 | $341 |
| Doxycycline Hyclate | 19 | $221 |
| Mupirocin | 26 | $205 |
| Azelastine Hcl | 12 | $144 |
| Ondansetron OdtOndansetron | 19 | $131 |
| Famotidine | 34 | $128 |
| Omeprazole | 25 | $109 |
| Tramadol Hcl | 14 | $17 |
Paid to pharmacies, not to this prescriber.
Other otolaryngology in Flowood
- John HinesFlowood$4K
- Elizabeth SchimmelFlowood$3K
- Benjamin JeffcoatFlowood$2K
- Stephen LeeFlowood$1K
- Scott HarrisonFlowood$1K
- Beverly FulcherFlowood$701
- Raymond WeissOcean Springs$258K
- Robert YarberTupelo$7K
- Charles WilsonOcean Springs$7K
- Gregory PippinMcComb$6K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.